These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 23345543)
21. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes. Kim SY; Kim BW; Pyo JY; Hong SW; Chang HS; Park CS World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384 [TBL] [Abstract][Full Text] [Related]
22. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma. Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807 [TBL] [Abstract][Full Text] [Related]
23. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection]. Huang H; Xu Z; Wang X; Wu Y; Liu S Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598 [TBL] [Abstract][Full Text] [Related]
24. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence. Hall CM; Snyder SK; Maldonado YM; Lairmore TC Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Zhao H; Huang T; Li H Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667 [TBL] [Abstract][Full Text] [Related]
26. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522 [TBL] [Abstract][Full Text] [Related]
27. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study. de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009 [TBL] [Abstract][Full Text] [Related]
28. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years. Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725 [TBL] [Abstract][Full Text] [Related]
29. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size. Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489 [TBL] [Abstract][Full Text] [Related]
30. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814 [TBL] [Abstract][Full Text] [Related]
31. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma. Kang IK; Kim K; Park J; Bae JS; Kim JS Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338 [TBL] [Abstract][Full Text] [Related]
32. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma. Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552 [TBL] [Abstract][Full Text] [Related]
33. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
34. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma. Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816 [TBL] [Abstract][Full Text] [Related]
36. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of recurrent papillary thyroid cancer. Zhu J; Wang X; Zhang X; Li P; Hou H Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921 [TBL] [Abstract][Full Text] [Related]
39. Number of tumor foci predicts prognosis in papillary thyroid cancer. Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041 [TBL] [Abstract][Full Text] [Related]
40. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma. Hu D; Lin H; Zeng X; Wang T; Deng J; Su X World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]